RxDoctor Payments Data

Adam Pleas, MD

Otolaryngology · Omaha, NENPI 1639374572

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 100.0% of the total across 97 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 16 manufacturers reported payments, led by Inspire Medical Systems, Inc. at 40.2% of the total. 2025 is the largest year on record at $924, 3.6 times the $255 reported in 2019. Among otolaryngology clinicians in NE with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.

$3,559in general payments, 2019–2025

Across 97 payments — averaging $36.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Inspire Medical Systems, Inc.$1K
  • Sanofi$869
  • Stryker$246
  • Medtronic$187
  • Regeneron Healthcare Solutions, Inc.$175
  • Intersect ENT, Inc.$163
  • plus $490 from 10 others

What the payments were for

  • Food & beverage$3,559100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$3,559 in reported general payments places this provider in the 90th percentile of 86 otolaryngology providers in Nebraska.

See all otolaryngology providers in Nebraska

Medicare billing

Part B allowed, 2024
$82,299
Medicare patients
293
Services billed
743

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Famotidine160$1,449
Fluticasone Propionate78$1,199
Montelukast Sodium106$1,020
Omeprazole70$772
Ipratropium Bromide51$723
Azelastine Hcl13$640
Pantoprazole Sodium38$519
Doxycycline Hyclate18$242
Amoxicillin-Clavulanate PotassAmoxicillin/Potassium Clav15$127
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen26$121
Ondansetron Hcl27$110
Cephalexin16$81
Mupirocin17$65
Sulfamethoxazole-TrimethoprimSulfamethoxazole/Trimethoprim12$63
Prednisone18$41

Paid to pharmacies, not to this prescriber.

Other otolaryngology in Omaha

See the full list for Nebraska

Where these figures come from

Is this you, or does something look wrong? →